At the end of the third quarter of 2025, Intuitive Surgical had placed 10,763 of its da Vinci surgical robot systems into ...
Intuitive Surgical, Inc. stock: da Vinci robotics leader with 80% share, recurring revenue, fast procedure growth and solid ...
ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory ...
One stock that seems to fit the bill is Intuitive Surgical (NASDAQ: ISRG). This robotic surgery pioneer gained 8% in 2025 -- underperforming the broader market. But given enough time, it could help ...
3d
How Investors May Respond To Intuitive Surgical (ISRG) Surging da Vinci Usage and New FDA Approvals
In recent days, Intuitive Surgical reported strong demand for its da Vinci robotic systems, with procedure volumes rising ...
Both companies are high-quality MedTech leaders, but their upside profiles diverge. Stryker’s diversification, consistent ...
Intuitive Surgical ISRG reported third-quarter 2024 adjusted earnings per share (EPS) of $1.84, which beat the Zacks Consensus Estimate of $1.65 by 11.5%. The bottom line improved 26% year over year.
With no fresh headline catalyst, Intuitive Surgical (ISRG) is drawing attention for its recent share performance as investors ...
Shares of Intuitive Surgical (NASDAQ: ISRG) were pulling back today as a strong fourth-quarter earnings report didn't seem to be enough to justify the medical device maker's lofty valuation. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback